Serial 97232109

Live / Registered — Registered (as of 31 Dec 2024)

What this means for you

Registered since 31 Dec 2024. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
97232109
Registration number
7634285
Mark type
Design / logo
Filed
21 Jan 2022
Published for opposition
20 Feb 2024
Registered
31 Dec 2024
Attorney of record
Timothy T. Wang

Goods and services

  • Class 005 — Pharmaceuticals: Vaccines; Anti-cancer preparations; Biological preparations for the treatment of anemia, cancer, cardiovascular system diseases, central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases, autoimmune diseases, bacteria-based diseases and infectious diseases; Chemical preparations for pharmaceutical or medical purposes, namely, for treatment of anemia, cancer, cardiovascular system diseases, central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases, autoimmune diseases, bacteria-based diseases and infectious diseases; Cytostatics for pharmaceutical purposes; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; Diagnostic reagents for medicinal use; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of antibody-drug conjugate that facilitate the delivery of pharmaceutical preparations; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Medicinal preparations for anemia, cancer, cardiovascular system diseases, central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases, autoimmune diseases, bacteria-based diseases and infectious diseases; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention of anemia, cancer, cardiovascular system diseases, central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases, autoimmune diseases, bacteria-based diseases and infectious diseases; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations, namely, elixirs for the treatment of anemia, cancer, cardiovascular system diseases, central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases, autoimmune diseases, bacteria-based diseases and infectious diseases; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Therapeutic pharmaceutical for the treatment of anemia, cancer, cardiovascular system diseases, central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases, autoimmune diseases, bacteria-based diseases and infectious diseases; Tumor suppressing agents

Owner

Prosecution history

  • 31 Dec 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 31 Dec 2024 — REGISTERED-PRINCIPAL REGISTER
  • 09 Dec 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
  • 09 Dec 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
  • 07 Dec 2024 — STATEMENT OF USE PROCESSING COMPLETE
  • 26 Sept 2024 — USE AMENDMENT FILED
  • 07 Dec 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
  • 26 Sept 2024 — TEAS STATEMENT OF USE RECEIVED
  • 16 Apr 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
  • 04 Mar 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 20 Feb 2024 — PUBLISHED FOR OPPOSITION
  • 31 Jan 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 31 Jan 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 12 Jan 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 03 Jan 2024 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

View this trademark record on Marksy